Kaposi's sarcoma-associated herpesvirus (KSHV; human herpesvirus 8) encodes
a chemokine-like G protein-coupled receptor (KSHV-GPCR) that is implicated
in the pathogenesis of Kaposi's sarcoma (KS). Since endothelial cells appe
ar to be targets for the virus, we developed an in vitro mouse lung endothe
lial cell model in which KSHV-GPCR is stably expressed and KSHV-GPCR signal
ing was studied. In mouse lung endothelial cells: 1) HSHV-GPCR does not exh
ibit basal signaling through the phosphoinositide-specific phospholipase C
pathway but inositol phosphate production is stimulated by growth-related o
ncogene a (Gro-alpha) via a pertussis toxin (PTX) -insensitive pathway; 2)
KSHV-GPCR signals basally through a PTX-sensitive pathway leading to a lowe
ring of intracellular cAMP level that can be lowered further by Gro alpha a
nd increased by interferon gamma -inducible protein 10; 3) KSHV-GPCR stimul
ates phosphatidylinositol 3-kinase via a PTX-insensitive mechanism; and 4)
KSHV-GPCR activates nuclear factor-kappaB (NF-kappaB) by a PTX-sensitive GB
gamma subunit-mediated pathway. These data show that KSHV-GPCR couples to
at least two G proteins and initiates signaling via at least three cascades
in endothelial cells thereby increasing the complexity of regulation of en
dothelial cell function by KSHV-GPCR that may occur during viral infection.